MarginsXMarginsX
Home › Markets › Health Care › BJDX

Bluejay Diagnostics Inc. (BJDX)

BJDX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.29
-12.26% on the day
Market cap
$2.6M
Nano cap
Revenue · 2022
$249K
No prior year to compare
Net income · 2022
-$9.3M
-3733.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2022-12-31, https://www.sec.gov/Archives/edgar/data/1704287/000121390024027305/0001213900-24-027305-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2022-12-31.

Profile

FieldValue
TickerBJDX on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001704287
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2022

LineValue
Revenue$249K
Net income-$9.3M
Operating income-$9.3M
Net margin-3733.1%
Operating margin-3741.5%
Revenue growthNo prior-year revenue to compare
Cash$10.1M
Total assets$13.5M
P/E (computed)Net income was not positive
P/S (computed)10.3×

Warning signs

Cash runway
13.5 months
$7.4M cash at September 30, 2026
Share count, 1 year
+885.2%
2025-11-06 to 2026-11-03 · +576820.9% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$73K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these financial statements are issued."
10-Q 2026-11-12
Cash and burn$7.4M cash; operating cash flow -$1.6M a quarter.Report 2026-09-30
Shares outstanding1,117,009 (2026-11-03); 1,814,133 a year earlier; 1,239,140 three years earlier. 1y figure adjusted for splits (1-for-16 overall); 3y figure adjusted for splits (1-for-6400 overall).Cover page 2026-11-03
Reverse splits, 3 years4; latest 1-for-4 on 2026-11-03Source 2026-11-03
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-06-17
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWolf & Company, P.C., Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $122K, sold $49K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$2.0M-$2.0M$7.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$2.3M-$1.5M$9.6MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$1.9M-$1.6M$3.7MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$1.4M-$1.5M$5.2MNo debt tagsNeeds four quarters10-K 2026-03-06
Q3 2025
2025-09-30
Not filed-$1.6M-$1.4M$3.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$2.0M-$2.1M$4.4MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$1.9M-$1.2M$3.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
Not filed-$1.4M-$1.5M$4.3MNo debt tagsNeeds four quarters10-K 2026-03-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-06-26
Latest annual report
ANNUAL REPORT
10-K2026-03-06
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-11-13
Latest proxy
PROXY STATEMENT
DEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 252 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+11.1%
1 month-21.6%
3 months-38.4%
Year to date-75.5%
1 year-89.5%
From 52-week high-89.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ICCMIceCure Medical Ltd.$0.7601+4.12%$2.6M
IVFINVO Fertility Inc.$2.40-7.69%$2.8M
VVOSVivos Therapeutics Inc.$0.0822-16.12%$2.8M
CODXCo-Diagnostics Inc.$0.2249-13.03%$2.4M
AMIXAutonomix Medical Inc.$1.10-19.71%$2.2M
XAIRBeyond Air Inc.$2.02-5.16%$3.4M
NXGLNexGel Inc$3.93+2.08%$1.9M
TNONTenon Medical Inc.$1.33-5.32%$3.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier